TrialThe pharmacogenomics journal2018

Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.

Yu Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.